Decision
EU binds Sanofi to commitments over flu vaccine disparagement
The EU Commission made Sanofi's commitments legally binding to stop disparaging a rival flu vaccine for vulnerable patients.
The European Commission has made commitments offered by Sanofi legally binding under EU antitrust rules. The commitments address the Commission's preliminary competition concerns. These concerns relate to Sanofi's alleged disparagement campaigns in Germany and France against Fluad. Fluad is the only enhanced flu vaccine for vulnerable patients that competes with Sanofi's Efluelda.
Headlines and summaries are written by AI for Outer News (RS Elite Pro s.r.o.) from the official text and are not reviewed by a person. They are not the official text and can contain mistakes: before you rely on one, read the original.
Original title: Commission accepts commitments by Sanofi to address possible anticompetitive disparagement of competing flu vaccine for vulnerable patients
Read the official decisionSource: European Commission · © European Union, 1995-2026 · CC BY 4.0